1
2
3
4
5
6
7
8
WHO ARE WE
OUR GOAL IS
JOINING
CONTACT
BLOGS
Our Suppliers
Why not Promote your Business
Search...
25
Jun 2020
Accord UK
Leyla Hannbeck
Accord UK Gold Partner
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

18
Jun 2020
Alliance Healthcare Distribution Ltd
Leyla Hannbeck
Alliance Healthcare Distribution Ltd Platinum Partner
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
BAPTT Group
Leyla Hannbeck
The BAPTT GROUP provides the complete package when refurbishing your pharmacy. Established for over 35 years we have a proven track record with many reference sites throughout the UK. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Buttercups Training
Leyla Hannbeck
Buttercups Training is a successful, well-established training provider with a wealth of experience and expertise. We deliver high quality training and apprenticeships to all members of the pharmacy team. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Cegedim Healthcare Solutions
Leyla Hannbeck
Cegedim is a leading provider of healthcare IT solutions. Our mission is to deliver products and services that are precisely matched to customers’ needs, drive efficiency, improve healthcare provisions and expedite improvements in patient care and outcomes. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Charles Russell Speechlys
Leyla Hannbeck
We have a specialist team of pharmacy lawyers who represent pharmacists and pharmacy owners on a full range of legal matters. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

18
Jun 2020
EMIS Health
Leyla Hannbeck
EMIS Health Platinum Partner Page
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Healthera Ltd
Leyla Hannbeck
Healthera is the NHS Accredited patient app. We focus on automating patient-initiated repeat ordering, saving staff time and gaining growth in dispensing through more adherent patients. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Hutchings Consultants
Leyla Hannbeck
Hutchings Consultants are the largest independent agents in the UK dealing exclusively with pharmacy sales and valuations. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
IPS Pharma
Leyla Hannbeck
IPS Pharma is an independent international pharmaceutical services company operating in three main areas: Unlicensed medicines (Unlicensed Imports and Specials), Clinical Trials and Special Obtains. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Napp Pharmaceutical Ltd
Leyla Hannbeck
Napp is committed to supporting AIM by offering commercial deals, value added services, sponsorship and representing themselves as Branded Manufacturers within this organisation. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

25
Jun 2020
Numark Pharmacy
Leyla Hannbeck
Numark Pharmacy Gold Partner
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Omnicell
Leyla Hannbeck
Omnicell are specialists in medication adherence, dispensing and administration technology and are a one-stop shop for automating pharmacy. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Positive Solutions
Leyla Hannbeck
Positive Solutions is proud to be partners with forward thinking modern pharmacies and provide IT solutions which support safe and efficient working practices. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Real World Analytics
Leyla Hannbeck
You work hard for every penny. But every day pharmacies will lose money through missed claims or service opportunities and wasted stock. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Rosemont Pharmaceuticals
Leyla Hannbeck
Rosemont Pharmaceuticals are the specialists in liquid medicines. With an unrivalled range of over 70 licensed liquid products and 50 years’ dedicated experience, we are the trusted experts. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
RxWeb
Leyla Hannbeck
The UK’s only web-based Patient Medical Record (PMR) system that exceeds the needs of all pharmacy types and sizes. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
Synergy Medical Europe
Leyla Hannbeck
For almost 13 years, Synergy Medical has been providing proven and reliable technology for the automated preparation of medication in Blister Packs. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

18
Jun 2020
The Pharmacy Partner
Leyla Hannbeck
The Pharmacy Partner Platinum Partner
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
VCare Systems Limited
Leyla Hannbeck
VCare Systems who offers eMAR software platform to several care homes now in response to COVID-19 is offering FREE platform to record vitals of service users to detect early symptoms of COVID-19. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

12
May 2020
VWV
Leyla Hannbeck
Premises (including dealing with Leasehold and Freehold Premises), Sale & Purchase of Pharmacy Businesses, NHS Pharmacy Contract Market Entry Applications, Dispute Resolution and Litigation. Read more...
Dear Member,

This is our April edition of the AIM Newsletter and yet again the biggest topic dominating is unfortunately the situation with COVID-19. We are concerned about the current pressure that the pharmacy teams are facing, and we would like to reassure you that we are raising these issues at every level and via every channel possible.

Whilst we have played a big role as an organisation, working with others, to boost the profile of pharmacy during this crisis, there is still a lot to do and there are barriers that we need to overcome.
We continue to lobby at every level possible nationally and via our representatives on LPCs locally – we also encourage all our members to write to their local MPs. The more MPs discuss the topic of pharmacy and the challenge that our members are facing the better.

This newsletter covers:
• The funding around COVID-19
• Additional COVID-19 costs to pharmacies (please fill in the questionnaire in spreadsheet and return to me by end of Wednesday this week)
• Easter break
• Deliveries
• Pharmacy practice matters

Funding in brief

As part of negotiations with PSNC, the Department of Health and Social Care (DHSC) has agreed a total of £300 million of advance funding into community pharmacies over the next two months. This is a temporary cash injection into community pharmacies that will have to be paid back at some point in the future. It will be paid as ‘uplifts’ to contractors’ January and February payments which are payable in early April and May. The two injections will be worth £200 million on 1st April 2020 (or soon after) and £100 million at the end of April/early May.

Separately, and not as part of negotiations with PSNC, the DHSC and NHS England have agreed to pay contractors £300 payment for installing screens – this will automatically be paid at the end of April and does not need to be claimed. This fee is outside of the global sum.

Please see below AIM statement regarding the funding:

“Whilst it is good to see some cash injection into this severely cash-starved sector, the delayed English pharmacy funding announcement does not allow for sufficient funding and will have a catastrophic effect on many pharmacies, not just financially, but by also having a deeply negative effect on the morale of all pharmacy staff.

We all know the partial closure of GPs and hospital services has put pharmacy in the front line of primary care in England and we have done everything asked of us, and more, by being there to deal with worried patients and members of the public and relieve pressure on GP’s and hospitals. This is despite staff shortages of self-isolation running at up to 15% and massively increased locum costs. Many staff have worked many extra hours before and after normal opening hours to keep community pharmacies functioning.

Unfortunately, this huge shock of not only continued under-funding, but also the increased operating costs that are directly due to our front-line role in supporting the Governments efforts against the COVID-19 pandemic, is a harsh message to hard working community pharmacies in England. Many businesses that were already losing money will now have to re-consider closure. With some branches currently temporarily closed due to staff shortages possibly not re-opening, that will put vulnerable communities at risk of not getting the pharmaceutical care they need.

In addition, pharmacy teams are putting their own health at risk looking after patients in communities without appropriate PPE. Despite the sector asking for this, it has not been forthcoming.

In a letter to Primary Care Executives on 17 March, Simon Steven highlighted that there will be funding “to cover your extra costs of responding to the coronavirus emergency” and that ”financial constraints must not and will not stand in the way of taking immediate and necessary action.” We, therefore, appeal for fairness, understanding and support from those in the position of power to allow this sector to continue caring for patients by urgently addressing these issues.”

IMPORTANT
It is important to note that further negotiations are taking place to cover the costs that contractors have occurred as part of preparations for COVID-19. As you can see in the AIM statement, we have referred to Simon Stevens letter to Primary Care CEOs telling them that there are no financial barriers standing in the way taking immediate and necessary action against COVID-19.

I have included attached a list of questions that we are currently seeking answers to in order to ensure these are passed on to PSNC to further negotiate with DHSC. I would be grateful if you could please fill in and return by the deadline on Wednesday 8th April.

I have queries with PSNC regarding the time period for this fee to be negotiated. We have highlighted the importance of extra cash for the sector not to be delayed and PSNC are hoping that this will be available by end of April.

AIMP Ltd is registered in England under No. 4613543 and VAT registration No. 864 2056 27. The registered office is at Leedale House, Railway Court, Doncaster, DN4 5FB
CONTACT
admin@aimp.co.uk
QUICK LINKS
Home
Copyright 2020| Website by ProjectPeach.co.uk